ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC
New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up
AGS-003 Increased Survival In Combination with Sunitinib
In Phase II Study, Vaccine IMA910 Stimulated Immune Response
Researchers Identify Subtype Demonstrating Angiogenesis
MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer
Imaging Technique Identifies Consequences Of Mutation
Researchers Call For New Approach To Peripheral Neuropathy Testing
Digital Microscope Blood Test Identifies Circulating Tumor Cells
Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome
Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended
Pathology In Operating Suite Cuts Need for More Surgery
UHC Expands Risk Models To Include 25 Cancer Variables
Trials Approved by NCI CTEP For The Month of February
Agency Expands Gleevec Label To Include Rare GIST Subset
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated
